Impact of pre-diagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis

Cancer Causes and Control

Volumn 26, Issue 10, 2015, Pages 1365-1373

  Fahey, Paul P ^a   Mallitt, Kylie Ann ^b   Astell Burt, Thomas ^a   Stone, Glenn ^a   Whiteman, David C ^c  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; Health behavior; Risk of death

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ALCOHOL CONSUMPTION; BEHAVIOR ASSESSMENT; BODY MASS; CANCER DIAGNOSIS; CANCER MORTALITY; DISEASE ASSOCIATION; DRUG USE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; HEALTH BEHAVIOR; HUMAN; OBESITY; PATIENT ATTITUDE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; ADENOCARCINOMA; ADVERSE EFFECTS; DRINKING BEHAVIOR; ESOPHAGUS TUMOR; META ANALYSIS; MORTALITY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ALCOHOL DRINKING; BODY MASS INDEX; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HEALTH BEHAVIOR; HUMANS; RISK FACTORS; SMOKING;

EID: 84941425450     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0635-z     Document Type: Review

References (30)

1. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington
2. Hongo M, Nagasaki Y, Shoji T (2009) Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24(5):729–735
3. American Cancer Society (2011) Global cancer facts & figures, 2nd edn. American Cancer Society, Atlanta
4. Corley DA, Kerlikowske K, Verma R, Buffler P (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124(1):47–56
5. Friedenreich CM, Neilson HK, Lynch BM (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46(14):2593–2604
6. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23(24):5814–5830
7. National Center for Health Statistics (2014) Health, United States, 2013: with special feature on prescription drugs. National Center for Health Statistics, Hyattsville
8. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012
9. Jüni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054–1060
10. Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2009) Introduction to meta-analysis. Wiley, Chichester
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557
12. Park SM, Lim MK, Shin SA, Yun YH (2006) Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 24(31):5017–5024. doi:10.1200/jco.2006.07.0243
13. Sundelöf M, Lagergren J, Ye W (2008) Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 44(11):1566–1571
14. Thrift A, Nagle C, Fahey P, Smithers B, Watson D, Whiteman D (2012) Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction. Cancer Causes Control 23(4):555–564. doi:10.1007/s10552-012-9913-1
15. Thrift AP, Nagle CM, Fahey PP, Russell A, Smithers BM, Watson DI, Whiteman DC, for the Australian Cancer Study Clinical Follow-Up S (2012) The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer. doi:10.1002/ijc.27420
16. Trivers KF, de Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, Abrahamson P, Rotterdam H, West AB, Fraumeni JF Jr, Chow W-H (2005) Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 3(3):225–230
17. Aghcheli K, Marjani HA, Nasrollahzadeh D, Islami F, Shakeri R, Sotoudeh M, Abedi-Ardekani B, Ghavamnasiri MR, Razaei E, Khalilipour E (2011) Prognostic factors for esophageal squamous cell carcinoma—a population-based study in Golestan Province, Iran, a high incidence area. PLoS One 6(7):e22152
18. Jing C, Huang Z, Duan Y, Xiao X, Zhang R, Jiang J (2012) Folate intake, methylenetetrahydrofolate reductase polymorphisms in association with the prognosis of esophageal squamous cell carcinoma. Asian Pac J Cancer Prev 13:647–651
19. Sehgal S, Kaul S, Gupta B, Dhar M (2012) Risk factors and survival analysis of the esophageal cancer in the population of Jammu, India. Indian J Cancer 49(2):245
20. Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T, Abe T, Kawai H, Tajika M, Kodaira T (2010) Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci 101(4):1001–1006
21. Wu X, Chen VW, Andrews PA, Ruiz B, Correa P (2007) Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic Whites and non-Hispanic Blacks in the United States: subsite and histology differences. Cancer Causes Control 18(6):585–593
22. Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Ma C (2009) p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clin Cancer Res 15(9):3103–3109
23. Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R (2007) Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med 10(1):32–37
24. Salek R, Bezenjani SE, Saedi HS, Ashkiki MHH, Hosainzade SM, Mohtashami S, Aghai MA, Bahar MM, Ghavamnasiri MR (2009) A geographic area with better outcome of esophageal carcinoma: is there an effect of ethnicity and etiologic factors? Oncology 77(3–4):172–177
25. Hubbard VS (2000) Defining overweight and obesity: what are the issues? Am J Clin Nutr 72(5):1067–1068
26. Ferronha I, Bastos A, Lunet N (2012) Prediagnosis lifestyle exposures and survival of patients with gastric cancer: systematic review and meta-analysis. Eur J Cancer Prev 21(5):449–452
27. Walter V, Jansen L, Hoffmeister M, Brenner H (2014) Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Ann Oncol. doi:10.1093/annonc/mdu040
28. Hong L, Zhang H, Zhao Q, Han Y, Yang J, Brain L (2013) Relation of excess body weight and survival in patients with esophageal adenocarcinoma: a meta-analysis. Dis Esophagus 26(6):623–627
29. Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev 15(5):434–451
30. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed 04 Sept 2014